The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Short Interest Up 21.0% in October

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) was the target of a large increase in short interest during the month of October. As of October 15th, there was short interest totalling 9,800 shares, an increase of 21.0% from the September 30th total of 8,100 shares. Based on an average daily volume of 21,900 shares, the short-interest ratio is presently 0.4 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Trading Down 0.1 %

Shares of Carlyle Group Inc. 4.625% Subordinated Notes due 2061 stock traded down $0.03 on Wednesday, hitting $19.80. 5,105 shares of the company were exchanged, compared to its average volume of 21,313. The company has a 50-day moving average price of $19.90 and a 200 day moving average price of $18.90. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a 1-year low of $15.90 and a 1-year high of $20.85.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, November 1st will be issued a dividend of $0.2891 per share. This represents a $1.16 annualized dividend and a dividend yield of 5.84%. The ex-dividend date of this dividend is Friday, November 1st.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Company Profile

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.